Partners
The ImmunoSABR project is consortium of 15 partners which has been created from leading Institutes within the EU . Working together their aim is to open up a new paradigm in treating metastatic cancer by obtaining clinical proof of concept for a novel bi-modal curative treatment strategy.
STAY INFORMED ?
If you want to stay informed about ImmunoSABR project, please subscribe to our newsletter.
CONTACT
The D-Lab / Precision Medicine
P.O. Box 616,
6200 MD Maastricht, The Netherlands
FUNDING
This project has received funding from the European Union’s. Horizon 2020 research and innovation programme under grant agreement No 733008